Fed Study of Alprazolam Extended-Release Tablets 3 mg to Xanax XR® Tablets 3 mg

This study has been completed.

Study NCT00650299 Information provided by Mylan Pharmaceuticals

First Received: March 30, 2008 Last Updated: March 31, 2008 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	August 2004
Primary Completion Date:	August 2004 (Final data collection date for primary outcome measure)